For several months now, the UK has been realising the seriousness of the facts concerning the administration of puberty blockers to minors, particularly in the wake of the scandal that rocked the Tavistock clinic specialising in gender transitions. The UK’s National Health Service has just made the decision to severely restrict minors’ access to puberty blockers—which will be limited to “exceptional circumstances.”
In July 2022, the NHS demanded the closure of the Tavistock clinic on the grounds that the treatments provided there were inappropriate and sometimes even dangerous for children. Now, as of this past Friday, June 9th, the NHS has broadened the lessons from Tavistock to apply to all clinics treating gender identity disorders.
